In studies, many participants regained a significant portion of lost weight after stopping GLP-1 therapy
Glucagon-like peptide-1 (7-36) amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells
PubMed CrossRef Idris I, Abdulla H, Tilbrook S, et al
If you have a history of significant GI issues or poor tolerance to other medications, semaglutide lower discontinuation rate (5-7% vs 12-18%) suggests better overall tolerability
Noveltreat 0.25 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight
Always follow the instructions on the product label and consult your doctor